Stonnington Group LLC lowered its position in Gilead Sciences, Inc. ( NASDAQ:GILD – Get Rating ) by 20.1% during the 4th quarter, Holdings Channel reports. The firm owned 15,251 shares of the biopharmaceutical company's stock after selling 3,829 shares during the quarter. Stonnington Group LLC's holdings in Gilead Sciences were worth $1,329,000 at the end of the most recent quarter. Several other hedge funds and other institutional investors also recently bought and sold shares of GILD. JFS Wealth Advisors LLC grew its stake in Gilead Sciences by 68.
https://www.dailypolitical.com/2023/03/19/stonnington-group-llc-sells-3829-shares-of-gilead-sciences-inc-nasdaqgild.html#dailypolitical
Sinun täytyy kirjautua sisään ennen kuin voit kommentoida.